Serum and Cerebrospinal Fluid Magnesium Levels, Glasgow Coma Scores, and In-Hospital Mortality in Patients with Acute Stroke

Basit Öğe Kaydı
dc.contributor.authorBayir, Ayseguel
dc.contributor.authorAk, Ahmet
dc.contributor.authorKara, Hasan
dc.contributor.authorSahin, Tahir Kemal
dc.date.accessioned2020-03-26T17:40:07Z
dc.date.available2020-03-26T17:40:07Z
dc.date.issued2009
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe aim of this study was to determine the relationship between serum and cerebrospinal fluid (CSF) magnesium (Mg(+2)) levels, Glasgow Coma Scores (GCS), and 7-day mortality in acute stroke patients. Patients with acute ischemic or hemorrhagic stroke arriving within the first 3 h of symptoms were included in the study. The control group consisted of healthy volunteers. GCS was determined, and blood and CSF samples were taken in order to establish serum and CSF glucose, Mg(+2), sodium, potassium, calcium, and chlorine levels. Mortality was recorded at 7 days after admission. CSF Mg(+2) in the ischemic infarct group was significantly lower than in the control group (p = 0.006). CSF Mg(+2) in the ischemic infarct patients with a GCS a parts per thousand currency signaEuro parts per thousand 8 were significantly lower (p = 0.002) than controls and in ischemic infarct patients with a GCS a parts per thousand yen9. In the ischemic stroke patients, CSF Mg(+2) and GCS were significantly correlated (r = 55, p = 0.031). CSF Mg(+2) levels in ischemic stroke patients who died within 7 days were significantly lower than controls, ischemic stroke patients who survived, and hemorrhagic stroke patients who died (p = 0.002, p = 0.042, and p = 0.005, respectively). Low CSF Mg(+2) levels in patients with acute ischemic stoke at admission predicted a higher 1-week mortality.en_US
dc.identifier.doi10.1007/s12011-009-8318-9en_US
dc.identifier.endpage12en_US
dc.identifier.issn0163-4984en_US
dc.identifier.issue1en_US
dc.identifier.pmid19165425en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage7en_US
dc.identifier.urihttps://dx.doi.org/10.1007/s12011-009-8318-9
dc.identifier.urihttps://hdl.handle.net/20.500.12395/23848
dc.identifier.volume130en_US
dc.identifier.wosWOS:000266646200002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherHUMANA PRESS INCen_US
dc.relation.ispartofBIOLOGICAL TRACE ELEMENT RESEARCHen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectIschemic strokeen_US
dc.subjectHemorrhagic strokeen_US
dc.subjectGlasgow Coma Scoreen_US
dc.subjectMagnesiumen_US
dc.subjectPrognosisen_US
dc.subjectMortalityen_US
dc.titleSerum and Cerebrospinal Fluid Magnesium Levels, Glasgow Coma Scores, and In-Hospital Mortality in Patients with Acute Strokeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu